On December 2, 2024, Saqib Islam, the Chief Executive Officer of SpringWorks Therapeutics Inc (SWTX, Financial), sold 49,000 shares of the company. Following this transaction, the insider now owns 1,014,368 shares of the company. The transaction details can be found in the SEC Filing.
SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer. The company is committed to advancing its pipeline of targeted oncology therapies and other innovative treatments.
The insider's recent sale is part of a broader trend observed over the past year. Saqib Islam has sold a total of 147,000 shares and has not purchased any shares during this period. The insider transaction history for SpringWorks Therapeutics Inc indicates that there have been 0 insider buys and 9 insider sells over the past year.
On the day of the recent sale, shares of SpringWorks Therapeutics Inc were trading at $41.37 each, giving the stock a market cap of $3.147 billion. Investors may consider various valuation metrics such as the GF Value, price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow when evaluating the stock.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
